Literature DB >> 22011697

Systemic steroids in acute exacerbation of COPD - from guidelines to bedside.

P-H Wang1, S-L Cheng, H-C Wang, H-T Chang, Y-L Hsu, Y-S Chen, C-Y Chang.   

Abstract

The optimal steroid dosages in AECOPD are still under debate. Admission records of patients in our hospital from January to December 2008 due to a diagnosis of AECOPD were reviewed. More wheezing and tachypnea were noted in the patients with a maximal daily prednisolone dose more than 60 mg. The steroid dose was higher in AECOPD without pneumonia than those concurrent with pneumonia. Those who had concurrent pneumonia had a higher risk of nosocomial infections. The study reflects the heterogeneity of AECOPD and that steroid dosages were determined by the clinical evaluation of the severity of illness and bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22011697     DOI: 10.5414/cp201588

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  2 in total

Review 1.  Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)? CON.

Authors:  Pedro J Marcos; José Luis López-Campos
Journal:  Med Sci (Basel)       Date:  2018-06-08

Review 2.  Acute exacerbation of COPD.

Authors:  Fanny W Ko; Ka Pang Chan; David S Hui; John R Goddard; Janet G Shaw; David W Reid; Ian A Yang
Journal:  Respirology       Date:  2016-03-30       Impact factor: 6.424

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.